AB Science announced the publication of a pathogenic mechanism triggered by mast cells in the amyotrophic lateral sclerosis (ALS) spinal cord that can be targeted by masitinib
PRESS RELEASE NEW DATA REVEAL THE DELETERIOUS ROLE OF ACTIVATED MAST CELLS ON MOTOR NEURONS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND THE PROTECTIVE EFFECT OBSERVED UPON TREATMENT…